Benzoic acid, 2-(cyclopentylamino)propyl ester, hydrochloride

Suppliers

Names

[ CAS No. ]:
67032-26-2

[ Name ]:
Benzoic acid, 2-(cyclopentylamino)propyl ester, hydrochloride

[Synonym ]:
Benzoesaeure-(2-cyclopentylamino-propylester),Hydrochlorid
1-Propanol,2-(cyclohexylamino)-,benzoate (ester),hydrochloride
Benzoic acid,2-(cyclohexylamino)propyl ester,hydrochloride
2-(cyclohexylamino)propyl benzoate hydrochloride(1:1)
benzoic acid-(2-cyclopentylamino-butyl ester),hydrochloride
benzoic acid-(2-cyclopentylamino-propylester),hydrochloride
Benzoesaeure-(2-cyclohexylamino-propylester),Hydrochlorid
2-Cyclohexylamino-1-propanol benzoate hydrochloride
Benzoesaeure-(2-cyclopentylamino-butylester),Hydrochlorid

Chemical & Physical Properties

[ Density]:
1.06g/cm3

[ Boiling Point ]:
369.4ºC at 760 mmHg

[ Molecular Formula ]:
C15H22ClNO2

[ Molecular Weight ]:
283.79400

[ Flash Point ]:
177.2ºC

[ Exact Mass ]:
283.13400

[ PSA ]:
38.33000

[ LogP ]:
3.95700

[ Index of Refraction ]:
1.533

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DG5790000
CHEMICAL NAME :
Benzoic acid, 2-(cyclopentylamino)propyl ester, hydrochloride
CAS REGISTRY NUMBER :
67032-26-2
LAST UPDATED :
199303
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C15-H21-N-O2.Cl-H
MOLECULAR WEIGHT :
283.83
WISWESSER LINE NOTATION :
L5TJ AMY1&1OVR &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 90,181,1947
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 90,181,1947

Related Compounds

  • (R)-4-Oxopiperidine-2-carboxylic acid hydrochloride
  • N-Methyl-1,6-diazaspiro[3.5]nonane-1-carboxamide
  • 3-(Bromomethyl)-5-chloro-2-(trifluoromethyl)pyridine
  • 2-((3,5-Dimethylisoxazol-4-yl)methyl)-2,7-diazaspiro[4.4]nonan-3-one
  • 2,5-Dimethyl-4-hydroxy-3(2H)-furanone-13C2
  • 4-(Pyridin-3-yl)-1,8-dioxa-4,11-diazaspiro[5.6]dodecan-3-one
  • tert-butyl N-[2-methyl-3-(methylamino)propyl]carbamate
  • N-Methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-3-carboxamide
  • (2S,3S,4R)-2-(hydroxymethyl)oxolane-3,4-diol
  • 4-(Methoxymethyl)-1-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.